| Literature DB >> 36211492 |
Yang Liu1,2, Md Abul Kalam Azad2, Xiangfeng Kong1,2, Qian Zhu2, Zugong Yu1.
Abstract
Intrauterine growth retardation (IUGR) results in intestinal dysfunction contributing to metabolic syndrome and growth lag of piglets. Bile acid (BA) presents various bioactivities, including regulation roles in antioxidant, anti-inflammation, and glucose and lipid metabolism. Forty-eight weaned piglets were allocated to four groups in a 2 × 2 factorial arrangement with the effects of BA supplementation and IUGR challenge. Twenty-four IUGR piglets and 24 normal birth weight (NBW) piglets were allocated into two groups, respectively, including the control group fed with a basal diet, and the treatment group fed a basal diet supplemented with 400 mg/kg BA. The experiment lasted 28 days. The results indicated that BA improved liver and spleen indexes in IUGR piglets, whereas decreased blood RDW-CV and RDW-SD regardless of IUGR (P < 0.05). Dietary BA supplementation decreased plasma CAT activity and liver GSH concentration regardless of IUGR, whereas increased plasma GSH and liver H2O2 and decreased liver T-AOC in weaned piglets (P < 0.05). In addition, IUGR downregulated liver Nrf1 and Nrf2 expression levels, while BA supplementation upregulated the Nrf2 expression of liver in weaned piglets (P < 0.05). Dietary BA decreased (P < 0.05) jejunal GSH concentration and ileal CAT activity regardless of IUGR. Furthermore, IUGR upregulated (P < 0.05) jejunal SOD and CAT expression levels; however, dietary BA upregulated ileal Nrf1 (P < 0.05) and Keap1 (P = 0.07) expression levels in piglets regardless of IUGR. Moreover, IUGR upregulated the liver lipid synthesis (FAS) and downregulated HSL and SCD1 expression levels, while dietary BA downregulated liver FAS and SCD1 expression levels (P < 0.05). However, BA supplementation could enhance liver gluconeogenesis by upregulating (P < 0.05) the liver G6PC and PCK1 expression levels in the NBW piglets but not in the IUGR piglets. Collectively, these findings suggest that BA could regulate the redox status of weaned piglets by regulating the Nrf2/Keap1 pathway and improving liver glucose and lipid metabolism of IUGR piglets. These findings will provide a reference for the application of BA in swine production; moreover, considering the physiological similarity between pigs and humans, these findings will provide a reference for IUGR research in humans.Entities:
Keywords: antioxidant capacity; bile acid; immunity; intrauterine growth retardation; oxidative stress; weaned piglets
Year: 2022 PMID: 36211492 PMCID: PMC9534482 DOI: 10.3389/fnut.2022.991812
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Effects of dietary bile acid (BA) supplementation on liver and spleen indices in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| Liver weight (g) | 471.50 | 459.43 | 406.43 | 432.50 | 8.32 | 0.01 | 0.65 | 0.22 |
| Liver index (g/kg) | 25.27 | 27.36 | 26.46 | 29.27 | 0.41 | < 0.01 | 0.04 | 0.62 |
| Spleen weight (g) | 32.54 | 37.28 | 30.42 | 35.85 | 1.33 | 0.50 | 0.05 | 0.90 |
| Spleen index (g/kg) | 1.75 | 2.13 | 2.02 | 2.45 | 0.08 | 0.07 | 0.01 | 0.87 |
Values are presented as means with their pooled SEM (n = 11–12). P < 0.05 represents significantly difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA.
Effects of dietary bile acid (BA) supplementation on hematological profiles of weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| WBC (109/L) | 13.59 | 12.86 | 16.51 | 14.71 | 4.20 | 0.05 | 0.30 | 0.66 |
| HGB (g/L) | 99.08 | 108.00 | 101.33 | 101.73 | 1.36 | 0.45 | 0.08 | 0.11 |
| LYM (109/L) | 8.41 | 7.60 | 9.59 | 8.06 | 0.69 | 0.56 | 0.41 | 0.80 |
| MCV (fL) | 51.34 | 50.67 | 51.48 | 51.62 | 0.36 | 0.46 | 0.72 | 0.58 |
| MCH (pg) | 15.53 | 15.32 | 15.70 | 15.90 | 0.12 | 0.12 | 1.00 | 0.40 |
| MCHC (g/L) | 302.67 | 302.75 | 305.33 | 308.00 | 1.27 | 0.13 | 0.59 | 0.62 |
| MON (109/L) | 0.39 | 0.50 | 0.43 | 0.54 | 0.05 | 0.73 | 0.73 | 0.98 |
| MPV (fL) | 9.03 | 8.96 | 9.11 | 8.93 | 0.11 | 0.91 | 0.58 | 0.80 |
| NEU (109/L) | 2.29 | 2.67 | 3.05 | 3.61 | 2.39 | 0.24 | 0.51 | 0.90 |
| PCT (%) | 0.46 | 0.40 | 0.40 | 0.38 | 0.02 | 0.40 | 0.37 | 0.66 |
| PDW (%) | 15.02 | 15.21 | 14.90 | 15.17 | 0.05 | 0.42 | 0.02 | 0.67 |
| PLT (109/L) | 509.33 | 447.42 | 439.50 | 426.91 | 24.71 | 0.37 | 0.46 | 0.63 |
| RBC (1012/L) | 6.39 | 7.06 | 6.46 | 6.43 | 0.11 | 0.19 | 0.13 | 0.10 |
| RDW-CV (%) | 20.82 | 19.83 | 22.18 | 20.21 | 0.34 | 0.18 | 0.03 | 0.45 |
| RDW-SD (fL) | 40.68 | 38.10 | 43.16 | 39.53 | 0.66 | 0.12 | 0.02 | 0.67 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significantly difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; WBC, white blood cells; LYM, lymphocytes; MID, intermediate cell; NEU, neutrophil; (LYM%), lymphocyte percentage; MID (%), intermediate cell percentage; RBC, red blood cells; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular; MCH, mean corpuscular; MCHC, mean corpuscular hemoglobin concentration; RDW-SD, red blood cell distribution width standard deviation; PLT, platelets; MPV, mean platelet volume; PCT, procalcitonin.
Effects of dietary bile acid (BA) supplementation on plasma cytokine and immunoglobulin of weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| IL-1 (pg/mL) | 114.60 | 120.80 | 109.78 | 112.55 | 1.79 | 0.07 | 0.21 | 0.63 |
| IL-2 (pg/mL) | 278.50 | 272.38 | 266.45 | 271.68 | 2.02 | 0.12 | 0.91 | 0.16 |
| IL-6 (pg/mL) | 672.02 | 674.75 | 665.73 | 671.09 | 5.15 | 0.64 | 0.71 | 0.90 |
| IL-10 (pg/mL) | 129.59 | 129.44 | 125.56 | 132.92 | 2.47 | 0.96 | 0.48 | 0.46 |
| INF-γ (pg/mL) | 36.07 | 36.46 | 37.04 | 36.30 | 0.77 | 0.80 | 0.91 | 0.72 |
| TNF-α (pg/mL) | 175.49 | 165.15 | 175.51 | 170.31 | 3.93 | 0.29 | 0.81 | 0.29 |
| IgA (mg/mL) | 0.67 | 0.64 | 0.68 | 0.64 | 0.01 | 0.93 | 0.09 | 0.96 |
| IgG (mg/mL) | 19.92 | 21.17 | 20.30 | 20.08 | 0.26 | 0.50 | 0.32 | 0.16 |
| IgM (mg/mL) | 16.23 | 13.19 | 14.45 | 13.84 | 0.34 | 0.37 | 0.01 | 0.05 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; IL, interleukin; Ig, immunoglobulin; IFN-γ, interferon-gamma; TNF-α, tumor necrosis factor-alpha.
Effects of dietary bile acid (BA) supplementation on the intestinal and liver cytokines expressions in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| ||||||||
|
| 1.00 | 1.12 | 1.12 | 0.90 | 0.11 | 0.91 | 0.89 | 0.51 |
|
| 1.00 | 1.00 | 0.64 | 0.75 | 0.10 | 0.14 | 0.78 | 0.78 |
|
| 1.00ab | 1.32a | 0.91b | 0.71a | 0.06 | < 0.01 | 0.63 | 0.04 |
|
| 1.00 | 0.86 | 0.66 | 0.86 | 0.07 | 0.22 | 0.82 | 0.21 |
|
| 1.00a | 0.77ab | 0.58b | 0.78ab | 0.09 | 0.27 | 0.94 | < 0.05 |
|
| 1.00 | 0.45 | 0.90 | 0.93 | 0.19 | 0.63 | 0.50 | 0.45 |
|
| ||||||||
|
| 1.00 | 2.34 | 1.72 | 2.34 | 0.19 | 0.31 | < 0.01 | 0.30 |
|
| 1.00 | 1.58 | 1.2 | 1.28 | 0.09 | 0.78 | 0.06 | 0.17 |
|
| 1.00 | 1.65 | 1.28 | 1.66 | 0.10 | 0.45 | 0.01 | 0.49 |
|
| 1.00 | 1.27 | 1.26 | 1.43 | 0.09 | 0.26 | 0.23 | 0.79 |
|
| 1.00 | 1.17 | 0.99 | 0.93 | 0.05 | 0.22 | 0.60 | 0.24 |
|
| 1.00 | 1.36 | 1.08 | 1.04 | 0.11 | 0.58 | 0.47 | 0.37 |
|
| ||||||||
|
| 1.00 | 1.40 | 1.46 | 1.56 | 0.13 | 0.23 | 0.33 | 0.57 |
|
| 1.00 | 1.73 | 1.05 | 1.22 | 0.12 | 0.32 | 0.05 | 0.23 |
|
| 1.00 | 1.12 | 1.02 | 1.08 | 0.06 | 0.92 | 0.50 | 0.82 |
|
| 1.00 | 1.19 | 0.79 | 1.44 | 0.04 | 0.90 | 0.02 | 0.17 |
|
| 1.00 | 0.87 | 0.81 | 1.38 | 0.11 | 0.44 | 0.29 | 0.09 |
|
| 1.00 | 1.44 | 1.17 | 1.60 | 0.10 | 0.40 | 0.03 | 0.97 |
|
| ||||||||
|
| 1.00 | 0.97 | 0.88 | 1.22 | 0.09 | 0.16 | 0.14 | 0.50 |
|
| 1.00 | 0.98 | 0.44 | 0.97 | 0.09 | 0.10 | 0.14 | 0.12 |
|
| 1.00 | 1.25 | 1.14 | 1.24 | 0.09 | 0.73 | 0.35 | 0.70 |
|
| 1.00 | 1.13 | 0.82 | 1.21 | 0.06 | 0.66 | 0.02 | 0.24 |
|
| 1.00 | 1.27 | 0.97 | 1.41 | 0.08 | 0.69 | 0.02 | 0.56 |
|
| 1.00 | 1.61 | 1.21 | 1.15 | 1.10 | 0.52 | 0.15 | 0.09 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; IL, interleukin; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ.
a, bMeans without a common letter within the same row indicate a significant difference (P < 0.05).
Effects of dietary bile acid (BA) supplementation on plasma and liver oxidant/antioxidant indices in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| ||||||||
| CAT (U/mL) | 9.96 | 8.90 | 11.02 | 8.75 | 0.33 | 0.47 | 0.01 | 0.33 |
| SOD (U/mL) | 12.82 | 13.20 | 12.79 | 12.87 | 0.18 | 0.63 | 0.54 | 0.07 |
| H2O2 (mmol/L) | 25.45 | 27.91 | 29.11 | 31.09 | 1.84 | 0.37 | 0.56 | 0.95 |
| GSH (μmol/L) | 12.35 | 14.95 | 16.33 | 18.55 | 0.45 | < 0.01 | 0.01 | 0.83 |
| MDA (nmol/mL) | 7.99 | 11.66 | 9.71 | 11.02 | 0.62 | 0.77 | 0.28 | 0.87 |
| T-AOC (mmol/mL) | 0.19a | 0.11b | 0.10b | 0.18ac | 0.01 | 0.67 | 0.87 | < 0.01 |
|
| ||||||||
| CAT (U/mgprot) | 60.88ab | 61.13ab | 63.11a | 53.12b | 1.90 | 0.45 | 0.20 | 0.02 |
| GSH (μmol/mgprot) | 1.09 | 0.73 | 1.07 | 0.74 | 0.04 | 0.85 | < 0.01 | 0.81 |
| H2O2 (mmol/gprot) | 55.24 | 70.34 | 63.40 | 74.00 | 2.73 | 0.27 | 0.02 | 0.67 |
| MDA (nmol/mgprot) | 0.20 | 0.20 | 0.23 | 0.24 | 0.01 | 0.08 | 0.65 | 0.74 |
| SOD (U/mgprot) | 29.21 | 28.86 | 31.22 | 28.59 | 0.61 | 0.48 | 0.23 | 0.35 |
| T-AOC (mmol/gprot) | 0.60 | 0.43 | 0.56 | 0.46 | 0.02 | 0.99 | < 0.01 | 0.44 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; CAT, catalase; GPX, glutathione peroxidase; MDA, malondialdehyde; SOD, superoxide dismutase; T-AOC, total antioxidant capacity.
a, b, cMeans without a common letter within the same row indicate a significant difference (P < 0.05).
Effects of dietary bile acid (BA) supplementation on liver antioxidant-related gene expression in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| 1.00 | 0.95 | 0.83 | 0.81 | 0.06 | 0.17 | 0.71 | 0.91 |
|
| 1.00 | 1.20 | 0.92 | 1.02 | 0.07 | 0.38 | 0.31 | 0.74 |
|
| 1.00 | 1.49 | 1.16 | 1.22 | 0.07 | 0.73 | 0.08 | 0.16 |
|
| 1.00 | 1.10 | 0.80 | 0.82 | 0.05 | 0.03 | 0.55 | 0.69 |
|
| 1.00 | 1.84 | 0.46 | 1.35 | 0.13 | 0.04 | < 0.01 | 0.93 |
|
| 1.00 | 1.23 | 0.99 | 1.16 | 0.07 | 0.46 | 0.07 | 0.52 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; CAT, catalase; GPX, glutathione peroxidase; Keap1, kelch-like ECH-associated protein 1; Nrf1, nuclear factor erythroid 2-related factor 1; Nrf2, nuclear factor erythroid 2-related factor; SOD, superoxide dismutase.
Effects of dietary bile acid (BA) supplementation on the small intestine oxidant/antioxidant indices in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| ||||||||
| CAT (U/mgprot) | 5.53 | 5.54 | 6.02 | 4.88 | 0.2 | 0.84 | 0.17 | 0.13 |
| GSH (μmol//gprot) | 89.77 | 73.47 | 93.26 | 68.58 | 2.44 | 0.85 | < 0.01 | 0.26 |
| MDA (nmol//mgprot) | 1.39 | 1.27 | 1.24 | 1.08 | 0.05 | 0.11 | 0.17 | 0.89 |
| SOD (U/mgprot) | 3.06 | 3.13 | 3.67 | 3.10 | 0.09 | 0.08 | 0.12 | 0.05 |
|
| ||||||||
| CAT (U/mgprot) | 3.09 | 2.22 | 3.06 | 2.71 | 0.11 | 0.27 | < 0.01 | 0.20 |
| GSH (μmol//gprot) | 74.85a | 68.04b | 83.06ac | 63.04b | 1.77 | 0.56 | < 0.01 | 0.02 |
| MDA (nmol//mgprot) | 1.22 | 1.06 | 1.23 | 1.18 | 0.03 | 0.33 | 0.13 | 0.44 |
| SOD (U/mgprot) | 3.37 | 3.86 | 3.66 | 3.57 | 0.08 | 0.99 | 0.17 | 0.06 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; CAT, catalase; GSH, glutathione; MDA, malondialdehyde; SOD, superoxide dismutase.
a, b, cMeans without a common letter within the same row indicate a significant difference (P < 0.05).
Effects of dietary bile acid (BA) supplementation on the small intestinal antioxidant-related gene expressions in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| ||||||||
|
| 1.00c | 1.45ab | 1.22abc | 1.48a | 0.08 | 0.02 | 0.11 | 0.01 |
|
| 1.00b | 1.42a | 1.07b | 1.37ab | 0.08 | < 0.01 | 0.10 | < 0.01 |
|
| 1.00 | 1.38 | 1.86 | 1.17 | 0.10 | 0.07 | 0.02 | 0.16 |
|
| 1.00 | 1.09 | 0.92 | 0.99 | 0.04 | 0.28 | 0.37 | 0.90 |
|
| 1.00 | 1.22 | 1.03 | 1.12 | 0.06 | 0.75 | 0.21 | 0.60 |
|
| 1.00 | 1.02 | 0.99 | 1.06 | 0.05 | 0.85 | 0.68 | 0.85 |
|
| ||||||||
|
| 1.00 | 1.23 | 1.08 | 1.07 | 0.05 | 0.97 | 0.12 | 0.12 |
|
| 1.00b | 1.39a | 1.00b | 1.17ab | 0.08 | 0.47 | 0.07 | 0.01 |
|
| 1.00 | 0.90 | 0.80 | 0.84 | 0.05 | 0.17 | 0.72 | 0.47 |
|
| 1.00 | 1.39 | 0.99 | 1.34 | 0.06 | 0.27 | 0.03 | 0.32 |
|
| 1.00b | 1.59a | 1.18b | 1.06b | 0.08 | 0.22 | 0.09 | 0.02 |
|
| 1.00 | 1.60 | 1.02 | 1.29 | 0.07 | 0.25 | < 0.01 | 0.19 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; CAT, catalase; GPX, glutathione peroxidase; Keap1, kelch-like ECH-associated protein 1; Nrf1, nuclear factor erythroid 2-related factor 1; Nrf2, nuclear factor erythroid 2-related factor; SOD, superoxide dismutase.
a, b, cMeans without a common letter within the same row indicate a significant difference (P < 0.05).
Effects of dietary bile acid (BA) supplementation on liver BA, glucose, and lipid metabolism-related gene expressions in weaned piglets with NBW and IUGR.
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
|
| ||||||||
|
| 1.00 | 0.27 | 1.20 | 0.78 | 0.14 | 0.20 | 0.04 | 0.57 |
|
| 1.00 | 0.81 | 1.51 | 1.63 | 0.22 | 0.16 | 0.94 | 0.74 |
|
| 1.00 | 0.85 | 0.85 | 0.79 | 0.06 | 0.34 | 0.36 | 0.69 |
|
| 1.00 | 1.09 | 0.73 | 0.82 | 0.07 | 0.06 | 0.52 | 0.99 |
|
| 1.00 | 0.80 | 0.86 | 0.69 | 0.08 | 0.44 | 0.24 | 0.93 |
|
| ||||||||
|
| 1.00 | 2.75 | 1.38 | 1.55 | 0.22 | 0.36 | 0.04 | 0.08 |
|
| 1.00b | 3.20a | 1.28b | 1.44b | 0.20 | < 0.05 | < 0.01 | < 0.01 |
|
| 1.00 | 2.59 | 1.26 | 2.17 | 0.24 | 0.86 | < 0.01 | 0.45 |
|
| 1.00 | 1.55 | 1.85 | 1.29 | 0.15 | 0.35 | 0.99 | 0.09 |
|
| ||||||||
|
| 1.00 | 2.05 | 1.63 | 1.16 | 0.20 | 0.75 | 0.47 | 0.07 |
|
| 1.00 | 1.36 | 1.19 | 1.26 | 0.11 | 0.82 | 0.32 | 0.51 |
|
| 1.00 | 0.52 | 1.37 | 0.94 | 0.10 | 0.04 | 0.02 | 0.88 |
|
| 1.00 | 1.48 | 0.66 | 0.81 | 0.10 | 0.02 | 0.12 | 0.40 |
|
| 1.00 | 0.66 | 0.89 | 0.56 | 0.07 | 0.44 | < 0.05 | 0.99 |
|
| 1.00 | 0.45 | 0.89 | 0.86 | 0.10 | 0.43 | 0.14 | 0.17 |
Values are expressed as means with their pooled SEM (n = 11–12). P < 0.05 represents significant difference.
NBW, normal birth weight; IUGR, intrauterine growth retardation; –BA, a basal diet without BA; +BA, a basal diet supplemented with 400 mg/kg BA; ACC, acetyl-CoA carboxylase; ATGL, adipose triglyceride lipase; BESP, bile salt export pump; CAT, catalase; CYP7A1, cytochrome P450 family 7 subfamily A member 1; CYP8B1, cytochrome P450 family 8 subfamily B member 1; CYP27A1, cytochrome P450 family 27 subfamily A member 1; FAS, fatty acid synthase; FXR, farnesoid X-activated receptor; GPX, glutathione peroxidase; G6PC, glucose-6-phosphatase; HSL, hormone-sensitive lipase; NTCP, sodium taurocholate cotransporting polypeptide; PC, pyruvate carboxylase; PCK1, phosphoenolpyruvate carboxykinase 1; PCK2, phosphoenolpyruvate carboxykinase 2; SCD1, stearoyl-Coenzyme A desaturase 1; SREBP/c, sterol regulatory element binding protein c.
a, bMeans without a common letter within the same row indicate a significant difference (P < 0.05).